MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
0.6090
+0.0038 (0.63%)
At close: Aug 1, 2025, 4:00 PM
0.6109
+0.0019 (0.32%)
After-hours: Aug 1, 2025, 6:12 PM EDT
Theseus Pharmaceuticals Market Cap
MetaVia has a market cap or net worth of $11.93 million as of August 1, 2025. Its market cap has decreased by -48.80% in one year.
Market Cap
11.93M
Enterprise Value
855.78K
1-Year Change
-48.80%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since August 5, 2016, MetaVia's market cap has decreased from $84.50M to $11.93M, a decrease of -85.88%. That is a compound annual growth rate of -19.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 11.90M | -32.00% |
| Dec 31, 2024 | 17.50M | -2.23% |
| Dec 29, 2023 | 17.90M | 280.85% |
| Dec 30, 2022 | 4.70M | -85.49% |
| Dec 31, 2021 | 32.40M | -62.41% |
| Dec 31, 2020 | 86.20M | 1,557.69% |
| Dec 31, 2019 | 5.20M | -55.17% |
| Dec 31, 2018 | 11.60M | -86.27% |
| Dec 29, 2017 | 84.50M | 16.23% |
| Dec 30, 2016 | 72.70M | -13.96% |
| Aug 5, 2016 | 84.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |